title: The role of the rheumatologist in managing pain therapy.
abstract: Despite the clinical importance of pain in patients with rheumatic diseases, rheumatologists have not delegated a proportionate amount of effort to its investigation and treatment. Some of the assumptions that have hindered progress in pain management for rheumatologists include a preference for immunologic research over pain research, a reluctance to provide opioid therapy, and inadequate compensation. Contrary to these assumptions, pain management is becoming an area of increasing research and clinical effort in the field of rheumatology. This article discusses how the barriers to effective pain management can be overcome, although the relative differential compensation for psychosocial versus interventional therapy remains a concern. In the future, rheumatologists will need to expend greater time and effort in the study of pain management to remain pertinent to the needs of their rheumatic disease patients.
authors.affiliation: Arthritis and Rheumatism Associates, 2021 K Street, NW, Suite 300, Washington, DC 20006, USA. dborenstein@arapc.com
authors.forename: David
authors.initials: D
authors.lastname: Borenstein
mesh_terms: D000700:Analgesics / Q000627:therapeutic use; D002908:Chronic Disease; D002983:Clinical Competence; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D020380:Needs Assessment; D019637:Orthopedic Procedures / Q000379:methods; D010146:Pain / Q000209:etiology* / Q000503:physiopathology; D059408:Pain Management; D026741:Physical Therapy Modalities; D010819:Physician's Role; D012216:Rheumatic Diseases / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D012219:Rheumatology / Q000193:education / Q000639:trends; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000700:Analgesics